“5-Azacytidine Treatment Inhibits the Development of Lung Cancer Models via Epigenetic Reprogramming and Activation of Cellular Pathways With Anti-Tumor Activity”. Medicine and Pharmacy Reports, vol. 97, no. 4, Sept. 2024, pp. 488-06, https://doi.org/10.15386/mpr-2777.